Reply

Clin Gastroenterol Hepatol. 2020 Feb;18(2):523-524. doi: 10.1016/j.cgh.2019.07.041. Epub 2019 Jul 25.

Authors

Tracey G Simon¹, Kathleen E Corey¹

Affiliation

¹ Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, Massachusetts.

PMID: 31352095
DOI: 10.1016/j.cgh.2019.07.041

No abstract available

Publication types

Letter
Comment

MeSH terms

Aspirin
Disease Progression
Fibrosis
Humans
Non-alcoholic Fatty Liver Disease*

Substances

Aspirin